Literature DB >> 10425340

Gelatin-stabilised microemulsion-based organogels: rheology and application in iontophoretic transdermal drug delivery.

S Kantaria1, G D Rees, M J Lawrence.   

Abstract

Gelatin-containing microemulsion-based organogels (MBGs) have been formulated using pharmaceutically acceptable surfactants and oils such as Tween 85 and isopropyl myristate. MBG formulations were subject to rheological study and their utility in transdermal drug delivery examined. Unlike most organogels, MBGs are electrically conducting and have been successfully employed in this study for the iontophoretic delivery of a model drug through excised pig skin. Iontophoresis using MBGs gave substantially higher release rates for sodium salicylate compared to passive diffusion, and fluxes were proportional to the drug loading and the current density. MBGs provide a convenient means of immobilising the drug and are rheologically similar to their hydrogel counterparts at comparable gelatin concentrations. MBGs also appear to offer improved microbial resistance in comparison to aqueous solution or hydrogels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425340     DOI: 10.1016/s0168-3659(99)00092-9

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

1.  Electric field-controlled benzoic acid and sulphanilamide delivery from poly(vinyl alcohol) hydrogel.

Authors:  Jarinya Sittiwong; Sumonman Niamlang; Nophawan Paradee; Anuvat Sirivat
Journal:  AAPS PharmSciTech       Date:  2012-10-13       Impact factor: 3.246

2.  Pluronic lecithin organogel (PLO) of diltiazem hydrochloride: effect of solvents/penetration enhancers on ex vivo permeation.

Authors:  Rabinarayan Parhi; Podilam Suresh; Subasini Pattnaik
Journal:  Drug Deliv Transl Res       Date:  2016-06       Impact factor: 4.617

3.  Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride.

Authors:  Sambhaji Pisal; Vijay Shelke; Kakasaheb Mahadik; Shivajirao Kadam
Journal:  AAPS PharmSciTech       Date:  2004-09-13       Impact factor: 3.246

4.  Lanolin-based organogel of salicylic acid: evidences of better dermatokinetic profile in imiquimod-induced keratolytic therapy in BALB/c mice model.

Authors:  Gajanand Sharma; Neelam Devi; Kanika Thakur; Ashay Jain; O P Katare
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

5.  Effects of crosslinking ratio, model drugs, and electric field strength on electrically controlled release for alginate-based hydrogel.

Authors:  Nophawan Paradee; Anuvat Sirivat; Sumonman Niamlang; Walaiporn Prissanaroon-Ouajai
Journal:  J Mater Sci Mater Med       Date:  2012-02-22       Impact factor: 3.896

Review 6.  Natural polysaccharide-based biodegradable polymeric platforms for transdermal drug delivery system: a critical analysis.

Authors:  Sobia Noreen; Jin-Xiang Ma; Muhammad Saeed; Fahad Pervaiz; Muhammad Farhan Hanif; Bilal Ahmed; Muhammad Irshad Farooq; Faizan Akram; Muhammad Safdar; Asadullah Madni; Muhammad Naveed; Li Chang-Xing
Journal:  Drug Deliv Transl Res       Date:  2022-04-30       Impact factor: 5.671

7.  Preparation and evaluation of microemulsion systems containing salicylic acid.

Authors:  Alia A Badawi; Samia A Nour; Wedad S Sakran; Shereen Mohamed Sameh El-Mancy
Journal:  AAPS PharmSciTech       Date:  2009-09-09       Impact factor: 3.246

8.  Development of span 80-tween 80 based fluid-filled organogels as a matrix for drug delivery.

Authors:  Charulata Bhattacharya; Nikhil Kumar; Sai S Sagiri; Kunal Pal; Sirsendu S Ray
Journal:  J Pharm Bioallied Sci       Date:  2012-04

Review 9.  Salicylate Poisoning Potential of Topical Pain Relief Agents: From Age Old Remedies to Engineered Smart Patches.

Authors:  Ashleigh Anderson; Aaron McConville; Laura Fanthorpe; James Davis
Journal:  Medicines (Basel)       Date:  2017-06-30

10.  Lecithin-linker microemulsion gelatin gels for extended drug delivery.

Authors:  Xiao-Yue Xuan; Yu-Ling Cheng; Edgar Acosta
Journal:  Pharmaceutics       Date:  2012-01-31       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.